Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Tencent Music Entertainment Group - ADR (TME) vs Twist Bioscience Corp (TWST) Price & Performance

Tencent Music Entertainment Group - ADRTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Tencent Music Entertainment Group - ADR vs Twist Bioscience Corp — how do they compare? Tencent Music Entertainment Group - ADR trades at $9.16 (market cap $15.08B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Tencent Music Entertainment Group - ADR is far larger — about 2.8× Twist Bioscience Corp's market cap, and Tencent Music Entertainment Group - ADR pays a 2.62% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.

TMETWST
Market Cap
$15.08B$5.45B
Sector
MediaHealth
52-Week High
$26.36$102.88
52-Week Low
$8.16$24.16
Enterprise Value
$11.85B$5.37B
Dividend Yield
2.62%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Tencent Music Entertainment Group - ADR

TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.

Read more on TME

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST